Micro Labs GmbH
- Legal form
- GmbH
- Seat
- Frankfurt, Germany
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 5 October 2026.
Identifiers
As the covered sources state them.
- VAT ID
- DE257539953
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 6 | — | 1 | 1 | 5 October 2026 | 5 October 2026 |
Awards
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
- Website
- https://www.microlabsgmbh.de/declared in a notice
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderEstablished supplier
Lieferung von Schienen und Schwellen 2027
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 4 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 26 Oct 2026, 15:47 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
MRTs Klinikum Fulda
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 31 Oct 2026
- Seat in the same federal state as the place of performance Evidence · checked 31 Oct 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 31 Oct 2026
Last checked 4 Nov 2026, 14:10 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Beschaffung und Austausch von vier Dampfsterilisatoren einschließlich Reindampferzeugung, Shuttle-System, IT-Anbindung und Vollservice – AEMP Klinikum Fulda
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
- Seat in the same federal state as the place of performance Evidence · checked 4 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 27 Oct 2026, 00:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Beschaffung von 17 Intensivbeatmungsgeräten
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 4 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 27 Oct 2026, 00:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Pankreatin (ATC-Code nach WHO: A09AA02)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 4 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 27 Oct 2026, 01:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Wirkstoff Indacaterol/Glycopyrroniumbromid (ATC-Code nach WHO: R03AL04)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 07:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Adalimumab (ATC-Code nach WHO: L04AB04)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 07:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Etanercept (ATC-Code nach WHO: L04AB01)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 07:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Golimumab (ATC-Code nach WHO: L04AB06)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 4 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 27 Oct 2026, 01:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open house Arzneimittelrabattverträge zum Wirkstoff Apixaban, ATC B01AF02
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 3 Nov 2026
- 6 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 03:31 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 5 October 2026.